Africa’s first Lassa fever vaccine clinical trial begins in Ghana
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced the first participant was ...
